Novo Nordisk's pricing approaches while in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, that has accused the company of value gouging, mentioning the stark contrast in between U.S. price ranges and people in Europe and copyright.Troubles with diabetic retinopathy: Diabetic retinopathy is a watch issue causing harm to the